COBAS C BILIRUBIN TOTAL GEN.3
FDA 510(k) clearance K131544 · decided 2013-07-17
Clearance details
- K-number
- K131544
- Device name
- COBAS C BILIRUBIN TOTAL GEN.3
- Applicant
- Roche Diagnostics
- Decision
- Substantially Equivalent
- Date received
- 2013-05-29
- Decision date
- 2013-07-17
- Days to decision
- 49 days
- Clearance type
- Traditional
- Product code
- CIG
- Device class
- 2
- Regulation number
- 862.1110
- Medical specialty
- Clinical Chemistry
- Advisory committee
- Clinical Chemistry
- Location
- Indianapolis, IN, US
- Third-party review
- No
- Expedited review
- No
+ Add to Predicate Builder ◉ Watch Roche Diagnostics
Need this as data, not a web page?
Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.
Similar devices under this product code
Devices cleared under the same product code - the starting set for predicate research.
Recalls involving this device
| Record | Firm | Date |
|---|---|---|
| Cobas c Bilirubin Total Gen.3 Catalog Number: 05795419190 - Product Usage: In vitro test f recall (Z-0153-2020) | Roche Diagnostics Operations, Inc. | 2019-10-16 |
| Bilirubin Total Gen.3, Cat. Nos. 05795397190, 05795419190, 05795320160, 05795338160, 05795 recall (Z-1145-2019) | Roche Diagnostics Corporation | 2019-04-13 |
PMA approvals by this applicant
| Record | Firm | Date |
|---|---|---|
| Elecsys Anti-HBs II, PreciControl Anti-HBs (P190034/S010) | Roche Diagnostics | 2025-05-22 |
| Elecsys Anti-HBe (P190005/S007) | Roche Diagnostics | 2025-05-22 |
| Elecsys Anti-HBe (P190005/S006) | Roche Diagnostics | 2024-10-03 |
| Elecsys Anti-HBs / Elecsys HBs II (P190034/S009) | Roche Diagnostics | 2024-10-03 |
| Elecsys Anti-HBs II (P190034/S008) | Roche Diagnostics | 2024-08-29 |
| Elecsys Anti-HBe (P190005/S005) | Roche Diagnostics | 2024-08-29 |
| Elecsys Anti-HBs II, PreciControl Anti-HBs (P190034/S007) | Roche Diagnostics | 2024-07-23 |
| Elecsys Anti-HBs II, PreciControl Anti-HBs (P190034/S005) | Roche Diagnostics | 2024-05-01 |